Financials

News Ideas Technicals Forecast

0SGC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ARBUTUS BIOPHARMA CORP NPV

Total assets of 0SGC for Q1 24 is 150.29 M USD, 4.08% more than the previous Q4 23. And total liabilities decreased by 7.11% in Q1 24 to 35.65 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—